126 related articles for article (PubMed ID: 20087043)
1. [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].
Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):115-8. PubMed ID: 20087043
[TBL] [Abstract][Full Text] [Related]
2. [Two cases treated with trastuzumab as primary chemotherapy].
Murakami K; Sakata H; Miyazawa Y; Matsushita K; Akutsu Y; Nishimori T; Yoneyama Y; Usui A; Kano M; Matsubara H; Ochiai T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1683-7. PubMed ID: 17940391
[TBL] [Abstract][Full Text] [Related]
3. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
[TBL] [Abstract][Full Text] [Related]
4. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
Untch M; Fasching PA; Konecny GE; Hasmüller S; Lebeau A; Kreienberg R; Camara O; Müller V; du Bois A; Kühn T; Stickeler E; Harbeck N; Höss C; Kahlert S; Beck T; Fett W; Mehta KM; von Minckwitz G; Loibl S
J Clin Oncol; 2011 Sep; 29(25):3351-7. PubMed ID: 21788566
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
6. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
Mazouni C; Hall A; Broglio K; Fritsche H; Andre F; Esteva FJ; Hortobagyi GN; Buzdar AU; Pusztai L; Cristofanilli M
Cancer; 2007 Feb; 109(3):496-501. PubMed ID: 17149760
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response].
Rai Y; Sagara Y; Sagara Y; Takahama T; Matsuyama Y; Ando M; Sagara Y; Ooi Y; Inoue K; Kurosumi M
Gan To Kagaku Ryoho; 2007 Jan; 34(1):65-8. PubMed ID: 17220672
[TBL] [Abstract][Full Text] [Related]
9. [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].
Ikeda M; Sonoo H; Oota Y; Fujii S; Shimo T; Miyake A; Seki M; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Kurebayashi J
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2917-20. PubMed ID: 21160270
[TBL] [Abstract][Full Text] [Related]
10. [Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].
Rai Y; Takahama T; Sagara Y; Sagara Y; Matsuyama Y; Ando M; Sagara Y; Ooi Y
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1297-300. PubMed ID: 16969028
[TBL] [Abstract][Full Text] [Related]
11. Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience.
Horiguchi J; Oyama T; Takata D; Rokutanda N; Nagaoka R; Odawara H; Tokiniwa H; Tozuka K; Kikuchi M; Sato A; Takeyoshi I
Anticancer Res; 2011 Sep; 31(9):3041-6. PubMed ID: 21868556
[TBL] [Abstract][Full Text] [Related]
12. [A case of locally advanced breast cancer successfully treated by pre-operative systemic therapy using paclitaxel and trastuzumab].
Suda T; Ishiguro K; Nishimura M
Gan To Kagaku Ryoho; 2008 Jun; 35(6):979-81. PubMed ID: 18633228
[TBL] [Abstract][Full Text] [Related]
13. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
[TBL] [Abstract][Full Text] [Related]
14. [A case of multicentric breast cancer in which an effect of neoadjuvant chemotherapy had a disparity].
Kashiwagi S; Kawajiri H; Noda S; Takashima T; Onoda N; Nakata B; Kato Y; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2775-7. PubMed ID: 21224709
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice.
Pernas S; Gil-Gil M; de Olza MO; Gumà A; Climent F; Petit A; Pla MJ; García-Tejedor A; López-Ojeda A; Falo C; Fernandez-Otega A; Mesia C; Pérez-Martin FJ; Urruticoechea A; Germà JR
Breast Cancer Res Treat; 2012 Aug; 134(3):1161-8. PubMed ID: 22772380
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
Yoshida T; Horiguchi J; Koibuchi Y; Kanoh T; Iijima K; Yoshida M; Kikuchi M; Takata D; Oyama T; Iino Y; Morishita Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):907-10. PubMed ID: 15222110
[TBL] [Abstract][Full Text] [Related]
17. [Effective combination chemotherapy using weekly trastuzumab and paclitaxel in the treatment of a recurrent breast cancer patient with liver metastases].
Tohnosu N; Kobayashi Y; Saito T; Shimizu T; Natsume T; Tanaka H; Maruyama T; Watanabe Y
Gan To Kagaku Ryoho; 2003 Jul; 30(7):989-92. PubMed ID: 12894716
[TBL] [Abstract][Full Text] [Related]
18. A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.
Hayashi H; Kimura M; Yoshimoto N; Tsuzuki M; Tsunoda N; Fujita T; Yamashita T; Iwata H
Breast Cancer; 2009; 16(2):136-40. PubMed ID: 18548321
[TBL] [Abstract][Full Text] [Related]
19. [Recurrent breast cancer obtained long-term survival with local treatment(surgery and stereotactic body radiotherapy)and systemic therapy].
Morioka E; Ohno Y; Noguchi M; Nakano Y; Noguchi M; Kosaka T; Takanaka T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1942-4. PubMed ID: 23267937
[TBL] [Abstract][Full Text] [Related]
20. [A long-surviving case of HER2-positive breast cancer with brain metastasis treated by multidisciplinary therapy].
Sugimoto H; Nakagawa T; Sato T; Nagahara M; Ishiba T; Kasahara M; Kawachi H; Kubota K; Sugihara K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2071-3. PubMed ID: 23267980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
